Patents Assigned to BIOVISTA, INC.
  • Compositions and methods for treating epilepsy
    Patent number: 11389435
    Abstract: Compositions and methods for treating epilepsy and epileptic syndromes are described herein. The compositions and methods include therapeutically effective amounts of one or more dimebolins, or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: February 7, 2020
    Date of Patent: July 19, 2022
    Assignee: BIOVISTA, INC.
    Inventors: Spyros Deftereos, Andreas Persidis
  • Compositions and methods for treating mitochondrial diseases
    Patent number: 10172854
    Abstract: The invention described herein relates to methods for treating mitochondrial diseases. In particular, the invention relates to methods for treating mitochondrial diseases by administering therapeutically effective amounts of one or more tetracyclic pyrazinoindoles, and/or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: August 22, 2017
    Date of Patent: January 8, 2019
    Assignee: BIOVISTA, INC.
    Inventors: Spyros Deftereos, Andreas Persidis
  • Compositions and methods for cancer treatment
    Patent number: 9795601
    Abstract: The invention described herein pertains to the use of oxazolidinone antibiotics, alone or in combination, in the treatment of cancer. In particular, the invention pertains to the treatment of malignant gliomas, thyroid cancer or melanoma, or borderline forms of malignant glioma, thyroid cancer or melanoma.
    Type: Grant
    Filed: December 15, 2011
    Date of Patent: October 24, 2017
    Assignee: BIOVISTA, INC.
    Inventors: Andreas Persidis, Spyros Deftereos
  • Compositions and methods for treating mitochondrial diseases
    Patent number: 9763939
    Abstract: The invention described herein relates to methods for treating mitochondrial diseases. In particular, the invention relates to methods for treating mitochondrial diseases by administering therapeutically effective amounts of one or more tetracyclic pyrazinoindoles, and/or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: September 19, 2017
    Assignee: BIOVISTA, INC.
    Inventors: Spyros Deftereos, Andreas Persidis
  • COMPOSITIONS AND METHODS FOR CANCER TREATMENT
    Publication number: 20130259800
    Abstract: The invention described herein pertains to the use of oxazolidinone antibiotics, alone or in combination, in the treatment of cancer. In particular, the invention pertains to the treatment of malignant gliomas, thyroid cancer or melanoma, or borderline forms of malignant glioma, thyroid cancer or melanoma.
    Type: Application
    Filed: December 15, 2011
    Publication date: October 3, 2013
    Applicant: BIOVISTA, INC.
    Inventors: Andreas Persidis, Spyros Deftereos
  • METHODS FOR TREATING MULTIPLE SCLEROSIS USING TETRACYCLIC PYRAZINOINDOLES
    Publication number: 20110268699
    Abstract: Methods and pharmaceutical compositions for treating multiple sclerosis are described. The methods and pharmaceutical compositions include a therapeutically effective amount of one or more tetracyclic pyrazinoindoles, and/or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: December 11, 2009
    Publication date: November 3, 2011
    Applicant: BIOVISTA, INC.
    Inventors: Spyros Deftereos, Andreas Persidis
  • COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS
    Publication number: 20110195049
    Abstract: Described herein are compositions and methods for treating multiple sclerosis. In particular, described herein are compositions that include one or more dimebolins and/or pharmaceutically acceptable salts thereof and methods for using the compositions for treating multiple sclerosis.
    Type: Application
    Filed: October 13, 2009
    Publication date: August 11, 2011
    Applicant: BIOVISTA, INC.
    Inventors: Spyros Deftereos, Andreas Persidis
  • COMPOSITIONS AND METHODS FOR TREATING EPILEPSY
    Publication number: 20110172262
    Abstract: Compositions and methods for treating epilepsy and epileptic syndromes are described herein. The compositions and methods include therapeutically effective amounts of one or more dimebolins, or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: September 15, 2009
    Publication date: July 14, 2011
    Applicant: BIOVISTA, INC.
    Inventors: Spyros Deftereos, Andreas Persidis